People · Operator

Carter Balfour

Named in public records as an officer, director or promoter · active 2009–2012 · Other Health Care, Other

2
Companies
2
Filings
$120.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Pentec Healthcare Infusions, Inc.Other Health CareSeries C$98.8M$2.3B2012
Portable Facilities Holdings, Inc.OtherSeries B$21.9M$363.9M2009
Operator network

Carter Balfour at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

BRIAN MORFITT · 3 companies · 1 sharedBRIAN MORFITTAndrew Carragher · 2 companies · 1 sharedAndrew CarragherArthur Rea, Jr. · 1 companies · 1 sharedArthur Rea, Jr.Jason Sondell · 1 companies · 1 sharedJason SondellJoseph Cosgrove · 1 companies · 1 sharedJoseph CosgroveRodney Boone · 1 companies · 1 sharedRodney BooneTim Kuehl · 1 companies · 1 sharedTim KuehlAndrew D. Cantwell · 2 companies · 1 sharedAndrew D. CantwellAndrew D Leonard · 1 companies · 1 sharedAndrew D LeonardJP O'Neil · 1 companies · 1 sharedJP O'NeilMark D McDonald · 1 companies · 1 sharedMark D McDonaldWayne D Foley · 1 companies · 1 sharedWayne D FoleyPentec Healthcare Infusions, Inc. · $98.8M raisedPentec Healthcare Inf…Portable Facilities Holdings, Inc. · $21.9M raisedPortable Facilities H…Carter BalfourCB
Carter Balfour Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Carter Balfour on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
BRIAN MORFITT13
Andrew D. Cantwell12
Andrew Carragher12
Tim Kuehl11
Rodney Boone11
Arthur Rea, Jr.11
JP O'Neil11
Andrew D Leonard11
Mark D McDonald11
Wayne D Foley11
Joseph Cosgrove11
Jason Sondell11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.